Skip to main content
. Author manuscript; available in PMC: 2010 Sep 15.
Published in final edited form as: Biochem Pharmacol. 2009 May 13;78(6):617–624. doi: 10.1016/j.bcp.2009.05.011

Figure 4.

Figure 4

Serum harmaline concentration vs. time curves in wild-type and Tg-CYP2D6 mice administered i.v. (A) or i.p. (B) with harmaline (5 and 15 mg/kg). Values represent mean ± SD (N = 3 at each time point). For each dose, significant difference in harmaline concentrations is shown for the variations of CYP2D6 genotype and time (P < 0.05; two-way ANOVA).